Results 161 to 170 of about 2,266 (184)

A LINE1-Nucleolin Partnership Regulates Early Development and ESC Identity

Cell, 2018
Michelle Percharde, Chih-Jen Lin, Yafei Yin   +2 more
exaly  

Atezolizumab, vemurafenib, and cobimetinib as first-line treatment for unresectable advanced BRAFV600 mutation-positive melanoma (IMspire150): primary analysis of the randomised, double-blind, placebo-controlled, phase 3 trial

Lancet, The, 2020
Ralf Gutzmer, Daniil Stroyakovskiy, Helen Gogas   +2 more
exaly  

Cancer Disparities by Race/Ethnicity and Socioeconomic Status

Ca-A Cancer Journal for Clinicians, 2004
Gopal K Singh
exaly  

Evolution and Diversity of Assembly-Line Polyketide Synthases

Chemical Reviews, 2019
Aleksandra Nivina, Chaitan Khosla
exaly  

Atezolizumab as first-line treatment in cisplatin-ineligible patients with locally advanced and metastatic urothelial carcinoma: a single-arm, multicentre, phase 2 trial

Lancet, The, 2017
Arjun V Balar, Matthew D Galsky, Jonathan E Rosenberg   +2 more
exaly  

Repression of Stress-Induced LINE-1 Expression Protects Cancer Cell Subpopulations from Lethal Drug Exposure

Cancer Cell, 2017
Benjamin Haley, Trinna L Cuellar, Jinfeng Liu   +2 more
exaly  

Ferroelectric memory for back-end-of-line 3D integration

Nature Reviews Materials, 2023
exaly  

Near-Field measurements over experimental modified goubau line

Proceedings of the Institution of Electrical Engineers, 1977
T.C.K. Rao, M.A.K. Hamid
openaire   +1 more source

Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study

Lancet, The, 2012
Laura E Via, Clifton E Barry Iii, Cesar Bonilla   +2 more
exaly  

Lenvatinib versus sorafenib in first-line treatment of patients with unresectable hepatocellular carcinoma: a randomised phase 3 non-inferiority trial

Lancet, The, 2018
Matsatoshi Kudo, Kwang-Hyub Han, Fabio Piscaglia   +2 more
exaly